Mark James Litton, Chief Business Officer at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 33,038 shares at $10.80 ($357K) on 2017-11-13, disclosed to the SEC on 2017-11-15.
Open-market sale of $357k ALDR by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.80 | 16,519 | $178K | 50.0% |
| 2 | $10.80 | 16,519 | $178K | 50.0% |
| Total | $10.80 avg | 33,038 | $357K | 100% |
| Filing → |
| ATHA | SELL | 2025-07-02 | $7K | — | Filing → |
| ATHA | SELL | 2025-01-03 | $14K | — | Filing → |
| ATHA | SELL | 2024-09-05 | $3K | — | Filing → |